Clinical Trials
2 trialsNCT04541381 2026-05-07
The PhOCus Trial: Implementation of Pharmacogenomic Testing in Oncology Care
University of Chicago
Phase NA Suspended
NCT03065062 2026-02-13
Study of the CDK4/6 Inhibitor Palbociclib (PD-0332991) in Combination With the PI3K/mTOR Inhibitor Gedatolisib (PF-05212384) for Patients With Advanced Squamous Cell Lung, Pancreatic, Head & Neck and Other Solid Tumors
Dana-Farber Cancer Institute
Phase 1 Suspended